Private Advisory Group LLC Buys New Shares in Intuitive Surgical, Inc. $ISRG

Private Advisory Group LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 23,897 shares of the medical equipment provider’s stock, valued at approximately $9,717,000.

A number of other hedge funds have also made changes to their positions in ISRG. Bank of America Corp DE increased its stake in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after buying an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the second quarter valued at $1,335,753,000. Amundi raised its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after acquiring an additional 193,096 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after acquiring an additional 184,044 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a research note on Thursday, July 30th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Thursday. Oppenheimer reaffirmed an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Insider Activity

In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total transaction of $529,000.00. Following the completion of the sale, the director owned 1,150 shares in the company, valued at $529,000. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares in the company, valued at $2,857,023.40. This trade represents a 6.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 39,456 shares of company stock valued at $17,769,124 over the last quarter. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Trading Down 2.1%

Shares of NASDAQ ISRG opened at $439.89 on Friday. The company has a market capitalization of $152.48 billion, a price-to-earnings ratio of 53.19, a price-to-earnings-growth ratio of 3.10 and a beta of 1.45. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The business has a 50 day simple moving average of $416.12 and a 200-day simple moving average of $430.38.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period last year, the business posted $2.40 earnings per share. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.